Damora Therapeutics Inc. Common Stock
Financials
Valuation Metrics
Damora Therapeutics Inc. Common Stock's Market Cap is $1.39B. At end of 2025 it was $31M. Ranked #2267 of 3,121 in US market (top 73%), #908 of 1,463 on NASDAQ (top 62%), #169 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 64%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.39B | US#2,267/3,121 Sec#169/266 |
| Revenue | $0.00 | US#2,889/3,121 Sec#196/266 |
| Net Income | $-263M | US—/3,121 Sec—/266 |
| Total Assets | $544M | US#2,736/3,121 Sec#155/266 |
| Net Assets | $516M | US#2,220/3,121 Sec#108/266 |
| Employees | 7 | US#2,795/3,121 Sec#226/266 |
| Value | ||
| P/B | 2.69x | US#1,633/3,121 Sec#78/266 |
| Profitability | ||
| ROE | -50.93% | US#2,683/3,121 Sec#157/266 |
| ROA | -48.35% | US#2,981/3,121 Sec#207/266 |
| Financial Health | ||
| Debt Ratio | 5.34% | US#42/3,121 Sec#15/266 |
| Total Debt | $0.00 | US—/3,121 Sec—/266 |
| Cash | $541M | US#1,025/3,121 Sec#54/266 |
| Current Ratio | 19.73x | US#122/3,121 Sec#27/266 |
| Performance | ||
| 1Y Return | 687.11% | US#4/3,121 Sec#2/266 |
| 1M Return | -30.36% | US#3,072/3,121 Sec#261/266 |
| From 52W High | -41.06% | US#2,475/3,121 Sec#195/266 |
| 1Y MDD | -72.38% | US#2,993/3,121 Sec#241/266 |
| Trading | ||
| Volume | 2,357,989 shares | US#1,845/3,121 Sec#194/266 |
| Trading Value | $53M | US#2,122/3,121 Sec#169/266 |
| Per Share | ||
| EPS | $-4.27 | US—/3,121 Sec—/266 |
| BPS | $8.38 | US#1,960/3,121 Sec#82/266 |
Company Info
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.